tiprankstipranks
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market
9966
Alphamab Oncology
RESEARCH TOOLSreports

Alphamab Oncology (9966) Ratios

2 Followers

Alphamab Oncology Ratios

HK:9966's free cash flow for Q2 2025 was ¥0.90. For the 2025 fiscal year, HK:9966's free cash flow was decreased by ¥ and operating cash flow was ¥<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 5.67 6.74 5.84 3.88 3.32
Quick Ratio
 5.29 6.41 5.55 3.71 3.23
Cash Ratio
 0.92 4.38 4.07 2.78 1.26
Solvency Ratio
 -0.13 0.54 -0.30 -0.51 -0.44
Operating Cash Flow Ratio
 0.91 0.84 -0.76 -0.78 -0.50
Short-Term Operating Cash Flow Coverage
 7.19 4.06 -2.70 -1.72 -0.71
Net Current Asset Value
¥ 1.21B¥ 1.30B¥ 1.09B¥ 934.67M¥ 1.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.08 0.12 0.16 0.24
Debt-to-Equity Ratio
 0.07 0.10 0.15 0.22 0.34
Debt-to-Capital Ratio
 0.07 0.09 0.13 0.18 0.25
Long-Term Debt-to-Capital Ratio
 0.05 0.07 0.09 0.09 0.08
Financial Leverage Ratio
 1.23 1.22 1.28 1.36 1.45
Debt Service Coverage Ratio
 -2.25 2.52 -1.48 -2.07 -0.77
Interest Coverage Ratio
 -43.81 10.18 -25.09 -30.44 -31.53
Debt to Market Cap
 0.02 0.06 0.04 0.04 0.06
Interest Debt Per Share
 0.13 0.20 0.28 0.39 0.70
Net Debt to EBITDA
 1.54 -5.91 6.41 1.85 0.46
Profitability Margins
Gross Profit Margin
83.01%90.58%74.75%73.50%97.93%
EBIT Margin
-26.81%15.78%-90.69%-259.15%-273.41%
EBITDA Margin
-15.66%24.50%-59.10%-234.85%-245.26%
Operating Profit Margin
-26.85%15.78%-139.66%-259.15%-284.63%
Pretax Profit Margin
-19.87%25.99%-96.26%-195.22%-282.44%
Net Profit Margin
-19.87%25.99%-96.26%-195.22%-282.44%
Continuous Operations Profit Margin
-19.87%25.99%-96.26%-195.22%-282.44%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
73.99%164.68%68.92%75.33%99.23%
Return on Assets (ROA)
-5.32%7.42%-9.85%-15.38%-15.25%
Return on Equity (ROE)
-6.26%9.08%-12.59%-20.91%-22.05%
Return on Capital Employed (ROCE)
-8.31%5.08%-16.34%-24.95%-20.10%
Return on Invested Capital (ROIC)
-8.15%4.95%-15.66%-22.53%-16.80%
Return on Tangible Assets
-5.32%7.49%-9.95%-15.54%-15.37%
Earnings Yield
-1.46%5.17%-3.76%-3.67%-3.98%
Efficiency Ratios
Receivables Turnover
 9.03 11.02 30.68 10.77 19.20
Payables Turnover
 1.35 1.54 2.03 2.51 0.11
Inventory Turnover
 0.88 0.74 0.70 0.68 0.05
Fixed Asset Turnover
 1.13 1.26 0.39 0.27 0.28
Asset Turnover
 0.27 0.29 0.10 0.08 0.05
Working Capital Turnover Ratio
 0.40 0.47 0.18 0.13 0.09
Cash Conversion Cycle
 183.22 290.83 352.76 422.03 3.57K
Days of Sales Outstanding
 40.42 33.12 11.90 33.89 19.01
Days of Inventory Outstanding
 412.59 495.06 520.35 533.67 6.98K
Days of Payables Outstanding
 269.79 237.35 179.49 145.53 3.43K
Operating Cycle
 453.01 528.18 532.25 567.56 7.00K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.27 0.22 -0.21 -0.32 -0.34
Free Cash Flow Per Share
 0.23 0.19 -0.25 -0.46 -0.51
CapEx Per Share
 0.04 0.02 0.04 0.14 0.17
Free Cash Flow to Operating Cash Flow
 0.85 0.90 1.18 1.43 1.49
Dividend Paid and CapEx Coverage Ratio
 6.60 9.75 -5.61 -2.32 -2.03
Capital Expenditure Coverage Ratio
 6.60 9.75 -5.61 -2.32 -2.03
Operating Cash Flow Coverage Ratio
 2.08 1.14 -0.79 -0.87 -0.50
Operating Cash Flow to Sales Ratio
 0.46 0.33 -0.93 -1.80 -2.20
Free Cash Flow Yield
2.83%5.92%-4.27%-4.84%-4.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -68.29 19.34 -26.60 -27.25 -25.12
Price-to-Sales (P/S) Ratio
 13.68 5.03 25.60 53.19 70.96
Price-to-Book (P/B) Ratio
 4.46 1.76 3.35 5.70 5.54
Price-to-Free Cash Flow (P/FCF) Ratio
 35.35 16.88 -23.43 -20.64 -21.64
Price-to-Operating Cash Flow Ratio
 29.74 15.15 -27.61 -29.55 -32.32
Price-to-Earnings Growth (PEG) Ratio
 0.47 -0.11 0.72 1.33 5.78
Price-to-Fair Value
 4.46 1.76 3.35 5.70 5.54
Enterprise Value Multiple
 -85.81 14.61 -36.91 -20.80 -28.47
Enterprise Value
 7.56B 2.29B 4.77B 8.15B 10.20B
EV to EBITDA
 -85.81 14.61 -36.91 -20.80 -28.47
EV to Sales
 13.44 3.58 21.81 48.85 69.82
EV to Free Cash Flow
 34.72 12.02 -19.97 -18.96 -21.30
EV to Operating Cash Flow
 29.46 10.79 -23.53 -27.14 -31.80
Tangible Book Value Per Share
 1.78 1.85 1.72 1.65 1.98
Shareholders’ Equity Per Share
 1.78 1.87 1.74 1.67 2.00
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.59 0.65 0.23 0.18 0.16
Net Income Per Share
 -0.12 0.17 -0.22 -0.35 -0.44
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.74 1.65 1.06 0.75 1.03
Research & Development to Revenue
 0.95 0.63 1.86 2.81 3.30
SG&A to Revenue
 0.15 0.12 0.36 0.52 0.53
Stock-Based Compensation to Revenue
 >-0.01 <0.01 0.06 0.08 0.06
Income Quality
 1.10 1.28 0.96 0.92 0.78
Currency in CNY